FDA Law

AUGUST 7, 2023

Site visits can also provide the opportunity to engage with patients on various topics, such as prototyping, trial design and conduct, and product launch and understand the challenges related to quality systems development and management in the product life cycle.

Patient-Centered 40

Patient-Centered Insurance Manufacturing Provider 40

GeriPal

MAY 5, 2022

And I’m using these personal sound amplification products, these PSAPs for young adults who are in their mid twenties, transitioning off of their parents’ insurance, or they’re going to college and they no longer qualify for Medicaid as a child, and they don’t have hearing aids anymore. Five big manufacturers.

IT 102

IT Screening Hospital Clinic 102

Physician's Weekly

JUNE 19, 2025

In this first installment of a two-part series, “An Arm and a Leg” shares lessons from Bob’s experience navigating a maze of pharmacies and insurance companies to get his daughter the medicine she needs. Because… Dan: Bob’s new job meant… a new insurance plan for the family. He left without it.

Insurance 52

Insurance IT Board-Certified Medical 52

Alabama Academy of Family Physicians

FEBRUARY 19, 2025

Senate SB 43 – Patient Price Transparency Bill What’s in the Bill: Sponsored by Sen. Additionally, health insurers would be barred from taking adverse action against providers for providing cost transparency. Any contractual clause that limits or penalizes providers for sharing this information would be unenforceable.

Insurance 130

Insurance Management Hospital Vaccination 130

FDA Law

JANUARY 11, 2022

The Court, however, would not dismiss similar allegations as applied to health insurer. Specifically, Amarin alleged that Hikma’s label “teaches CV risk reduction” due to “a notice regarding side effects for patients with CV disease” and an absence of a statement that the generic “should not be used for the CV indication….”

Insurance 52

Insurance Patients IT Manufacturing 52

FDA Law

JANUARY 11, 2022

The Court, however, would not dismiss similar allegations as applied to health insurer. Specifically, Amarin alleged that Hikma’s label “teaches CV risk reduction” due to “a notice regarding side effects for patients with CV disease” and an absence of a statement that the generic “should not be used for the CV indication….”

Insurance 52

Insurance Patients IT Manufacturing 52

FDA Law

SEPTEMBER 8, 2022

Wasserstein — Three patient advocate groups have sued the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS), challenging HHS’s 2020 Notice of Benefits and Payment Parameters (NBPP) rule. The patient, on the other hand, is no closer to meeting their deductible than before.

Insurance 83

Insurance Patients Manufacturing Patient-Centered 83

FDA Law

SEPTEMBER 14, 2021

PART 1: MAXIMUM FAIR PRICE PAYMENT LIMITATION UNDER MEDICARE PARTS B AND D AND THE COMMERCIAL INSURANCE MARKET. The MFP would be established through negotiations between HHS and the manufacturer and would incorporate foreign pricing benchmarks, as further described below. The four parts of Subtitle E are summarized in turn below.

Manufacturing 52

Manufacturing Insurance Government Patients 52

FDA Law

MAY 19, 2022

By Faraz Siddiqui — Last June, we blogged about a lawsuit brought by the Pharmaceutical Research and Manufacturers of America (PhRMA) challenging CMS’s ill-conceived Accumulator Adjustment Rule (“final rule”), which amended the Medicaid Rebate best price regulation. On Tuesday, May 17, 2022, the D.C. See 42 C.F.R. §§ 447.505(c)(8)-(12).

Manufacturing 40

Manufacturing Patients Insurance Government 40

Physicians News Digest

APRIL 2, 2025

By Julie Appleby Tim Winard knew he needed to buy health insurance when he left his management job in manufacturing to launch his own business. After speaking with an insurance agent, he decided against enrolling in an Affordable Care Act plan because he was concerned about the potential cost. Then the bill came.

Insurance 52

Insurance Screening Hospital Patient-Centered 52